首页> 外文OA文献 >T41. SAFETY PROFILE OF ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL FOR THE POTENTIAL TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT

【2h】

T41. SAFETY PROFILE OF ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL FOR THE POTENTIAL TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT

机译：T41。增强研究中的辅助Pimavanserin的安全谱，抗精神病患者不足患者精神分裂症潜在治疗的第3阶段试验

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Dragana Bugarski-Kirola; Rene Nunez; Ramzey Odetalla; Mohammed A Bari; Istvan Bitter; Peter D Feldman; I-Yuan (Cathy) Liu; Srdjan Stankovic;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Efficacy and Safety of Ixekizumab in the Treatment of Radiographic Axial Spondyloarthritis: Sixteen‐Week Results?From a Phase III III Randomized, Double‐Blind, Placebo‐Controlled Trial in Patients With Prior Inadequate Response to or Intolerance of Tumor Necrosis Factor Inhibitors [J] . Deodhar Atul, Poddubnyy Denis, Pacheco‐Tena Cesar, Arthritis & rheumatology. . 2019,第4期

机译：Ixekizumab在射线照相轴痛治疗中的疗效和安全性：十六周的结果？来自患者III III阶段的患者，对肿瘤坏死因子抑制剂的不容忍或不容忍的患者
2. Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: Results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year? [J] . Joel M. Kremer, Ricardo Blanco, Marek Brzosko, Arthritis & Rheumatism . 2011,第3期

机译：在对甲氨蝶呤反应不足的类风湿性关节炎患者中，Tocilizumab抑制结构性关节损伤：tocilizumab安全性随机对照试验的双盲治疗阶段的结果，并在一年内预防了结构性关节损伤？
3. Tocilizumab inhibits structural joint damage in rheumatoid arthritis patients with inadequate responses to methotrexate: results from the double-blind treatment phase of a randomized placebo-controlled trial of tocilizumab safety and prevention of structural joint damage at one year. [J] . Kremer JM, Blanco R, Brzosko M, Arthritis and Rheumatism . 2011,第3期

机译：在甲氨蝶呤反应不充分的类风湿关节炎患者中，Tocilizumab抑制结构性关节损伤：tocilizumab安全性随机对照试验的双盲治疗阶段的结果，并在一年内预防了结构性关节损伤。
4. C677T Methylenetetrahydrofolate Reductase (MTHFR) Gene Polymorphism and Treatment Response in Schizophrenia Patients [C] . Muthmainah Muthmainah, Nova Kurniasari, Mohammad Fanani, Health Science International Conference . 2017

机译：C677T甲基四乙烯酸还原酶（STHFR）基因多态性和精神分裂症患者的治疗反应
5. Synthesis of Fused Triazolo-Pyridobenzodiazepine Analogs for Use as Potential Atypical Antipsychotic Treatments in Schizophrenia. [D] . Sheehan, Megan. 2016

机译：融合的Triazolo-吡啶基苯并二氮杂pine类似物的合成，可用作精神分裂症的潜在非典型抗精神病药物。
6. T41. SAFETY PROFILE OF ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY A PHASE 3 TRIAL FOR THE POTENTIAL TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT [O] . Dragana Bugarski-Kirola, Rene Nunez, Ramzey Odetalla, 2020

机译：T41。辅助性PIMAVANSERIN在安全性研究中的安全性这是对精神分裂症的治疗反应不充分的潜在治疗精神分裂症的第三阶段试验
7. T42. HIGH ADHERENCE TO CURRENT ANTIPSYCHOTIC AND ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL TO EVALUATE THE TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT [O] . Brandon Abbs, Dragana Bugarski-Kirola, I-Yuan (Cathy) Liu, 2020

机译：T42。高粘附到目前的抗精神病药分类和辅助Pimavanserin在增强研究中，阶段3试验，以评估患者的精神分裂症治疗患者的治疗不足的抗精神病治疗

T41. SAFETY PROFILE OF ADJUNCTIVE PIMAVANSERIN IN THE ENHANCE STUDY, A PHASE 3 TRIAL FOR THE POTENTIAL TREATMENT OF SCHIZOPHRENIA IN PATIENTS WITH AN INADEQUATE RESPONSE TO ANTIPSYCHOTIC TREATMENT

著录项

引文网络

相似文献

相关主题

期刊订阅